Bariatric Dose-ranging Study With Dexmedetomidine

Abdominal Surgery Patients Clinical Trial

Official title: A Randomized, Double-blind, Controlled Study of Dexmedetomidine (Precedex) Infusion for Improving Control of Acute Autonomic Response During Laparoscopic Bariatric Surgery

Status Withdrawn

Clinical Trial Summary

After obtaining informed consent,80 morbidly obese ASA II-III patients undergoing laparoscopic bariatric surgery procedures would be randomly assigned to one of four study groups at UTSWMC at Dallas.Hemodynamic paarameters, recovery times, postoperative pain scores, the need for rescue analgesics and side effects will be recorded.The purpose of this study is to determine the optimal linfusion rate of dexmedetomidine for maintaining cardiovscular stability during general anesthesia.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Abdominal Surgery Patients

• NCT number: NCT00363935
• Study type: Interventional
• Source: University of Texas Southwestern Medical Center
• Status: Withdrawn
• Phase: Phase 4
• Start date: January 1, 2007
• Completion date: January 1, 2007